FC
BSX icon

Fairscale Capital’s Boston Scientific BSX Stock Holding History

Fairscale Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.54K Hold
200
– – 0.01% 324
2026
Q1 		$12.6K Hold
200
– – 0.01% 303
2025
Q4 		$19.1K Hold
200
– – 0.01% 274
2025
Q3 		$19.5K Hold
200
– – 0.01% 279
2025
Q2 		$21K Hold
200
– – 0.02% 265
2025
Q1 		$20.2K Hold
200
– – 0.02% 213
2024
Q4 		$17.9K Hold
200
– – 0.02% 227
2024
Q3 		$16.8K Hold
200
– – 0.01% 237
2024
Q2 		$15.6K Buy
+200
New +$14.6K 0.01% 239

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fairscale Capital's BSX Position: Q2 2026 in Review

Fairscale Capital held its Boston Scientific (BSX) position steady in Q2 2026 at 200 shares worth $8.54K. The position accounts for 0.01% of the portfolio, ranked #324.

Fairscale Capital first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $21K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fairscale Capital held 200 shares of Boston Scientific worth $8.54K as of Q2 2026.
  • Fairscale Capital left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.01% of Fairscale Capital's portfolio in Q2 2026, its #324 holding.
  • Fairscale Capital first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Fairscale Capital's Boston Scientific position peaked at $21K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.